BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11104733)

  • 21. Procaterol inhibits IL-1beta- and TNF-alpha-mediated epithelial cell eosinophil chemotactic activity.
    Koyama S; Sato E; Masubuchi T; Takamizawa A; Kubo K; Nagai S; Isumi T
    Eur Respir J; 1999 Oct; 14(4):767-75. PubMed ID: 10573218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase A- and phosphatidylinositol 3-kinase-dependent NF-kappaB activation.
    Wang P; Zhu F; Konstantopoulos K
    Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1445-56. PubMed ID: 20457835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The adenylyl cyclase-cAMP system suppresses TARC/CCL17 and MDC/CCL22 production through p38 MAPK and NF-kappaB in HaCaT keratinocytes.
    Qi XF; Kim DH; Yoon YS; Li JH; Song SB; Jin D; Huang XZ; Teng YC; Lee KJ
    Mol Immunol; 2009 Jun; 46(10):1925-34. PubMed ID: 19371952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of ICAM-1 by cytokines in human tracheal smooth muscle cells involves an NF-kappa B-dependent signaling pathway that is only partially sensitive to dexamethasone.
    Amrani Y; Lazaar AL; Panettieri RA
    J Immunol; 1999 Aug; 163(4):2128-34. PubMed ID: 10438953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
    Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
    Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. cAMP inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts.
    Zitnik RJ; Zheng T; Elias JA
    Am J Physiol; 1993 Mar; 264(3 Pt 1):L253-60. PubMed ID: 7681633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia.
    Kim DH; Lerner A
    Blood; 1998 Oct; 92(7):2484-94. PubMed ID: 9746789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids.
    John M; Hirst SJ; Jose PJ; Robichaud A; Berkman N; Witt C; Twort CH; Barnes PJ; Chung KF
    J Immunol; 1997 Feb; 158(4):1841-7. PubMed ID: 9029124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of RANTES chemokine expression in human astrocytic cells is dependent upon activation of NF-kappaB transcription factor.
    Li QQ; Bever CT; Burt DR; Judge SI; Trisler GD
    Int J Mol Med; 2001 May; 7(5):527-33. PubMed ID: 11295116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of cAMP-dependent pathways in human airway smooth muscle cells inhibits TNF-alpha-induced ICAM-1 and VCAM-1 expression and T lymphocyte adhesion.
    Panettieri RA; Lazaar AL; Puré E; Albelda SM
    J Immunol; 1995 Mar; 154(5):2358-65. PubMed ID: 7532667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes.
    Kanda N; Mitsui H; Watanabe S
    J Allergy Clin Immunol; 2004 Dec; 114(6):1403-9. PubMed ID: 15577845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of rolipram, a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharide-induced uveitis in rats.
    Chi ZL; Hayasaka S; Zhang XY; Hayasaka Y; Cui HS
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2497-502. PubMed ID: 15277469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM; Barnes PJ; Meja K; Giembycz MA
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells.
    Hall IP; Widdop S; Townsend P; Daykin K
    Br J Pharmacol; 1992 Oct; 107(2):422-8. PubMed ID: 1384913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor alpha (TNF-alpha)-induced RANTES chemokine expression via activation of NF-kappaB and p38 MAP kinase: roles of TNF-alpha in alcoholic liver diseases.
    Hirano F; Komura K; Fukawa E; Makino I
    J Hepatol; 2003 Apr; 38(4):483-9. PubMed ID: 12663241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RANTES release by human airway smooth muscle: effects of prostaglandin E(2) and fenoterol.
    Lazzeri N; Belvisi MG; Patel HJ; Chung KF; Yacoub MH; Mitchell JA
    Eur J Pharmacol; 2001 Dec; 433(2-3):231-5. PubMed ID: 11755157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitor of nuclear factor-kappaB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expression.
    Kamthong PJ; Wu M
    Biochem J; 2001 Jun; 356(Pt 2):525-30. PubMed ID: 11368781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulindac suppresses nuclear factor-kappaB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis.
    Wieser F; Vigne JL; Ryan I; Hornung D; Djalali S; Taylor RN
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6441-7. PubMed ID: 16159934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells.
    Hallsworth MP; Twort CH; Lee TH; Hirst SJ
    Br J Pharmacol; 2001 Feb; 132(3):729-41. PubMed ID: 11159726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of RANTES and ICAM-1 expression in murine mesangial cells.
    Satriano JA; Banas B; Luckow B; Nelson P; Schlondorff DO
    J Am Soc Nephrol; 1997 Apr; 8(4):596-603. PubMed ID: 10495789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.